3 results
Approved WMOCompleted
Primary objective: to explore 18F-FDHT PET/CT as a predictor of response in patients with metastasized CRPC to be treated with enzalutamide. Secondary objective: to explore 18F-FDHT PET/CT as a predictor of clinical survival endpoints in patients…
Approved WMOCompleted
To investigate the influence of concomitant enzalutamide on the pharmacokinetics of cabazitaxel.
Approved WMOCompleted
To compare treatment with enzaluatmide plus BI836845 with treatment with enzalutamide only.